oa Audit of the Management of Patients Admitted to Hamad General Hospital with Community-Acquired Pneumonia

References

1. Goss CH, Rubenfeld GD, Park DR, et al., Cost and incidence of social co-morbidities in low-risk patients with community-acquired pneumonia admitted to a public hospital. Chest. 2003; 124::2148–2155.
   [Google Scholar]
2. Clinical guidelines, available at: http://intranet/PDF/Clinical%20Guidlines/Guidelines%20%20for%20treatment%20of%20common%20Medical%20conditions/Community_Acquired_Pneumonia.pdf..
3. Yealy DM, Auble TE, Stone RA, et al., Effect of increasing the in tensity of implementing pneumonia guidelines: a randomized, controlled trial. Ann Intern Med. 2005; 143::881–894.
   [Google Scholar]
4. Marrie TJ, Lau CY, Wheeler SL, et al., A controlled trial of a critical pathway for treatment of community-acquired pneumonia: CAPITAL Study Investigators; Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin. JAMA. 2000; 283::749–755.
   [Google Scholar]
5. Atlas SJ, Benzer TL, Borowsky LH, et al., Safely increasing the proportion of patients with community-acquired pneumonia treated as outpatients: an interventional trial. Arch Intern Med. 1998; 158::1350–1356.
   [Google Scholar]
6. Frei CR, Restrepo ML, Mortensen EM, et al., I mpact of guidelineconcordant empiric antibiotic therapy in community-acquired pneumonia. Am J Med. 2006; 119::865–871.
   [Google Scholar]
7. Maxwell DJ, Mcintosh KA, Pulver LK, et al., Empiric management of community-acquired pneumonia in Australian emergency departments. Med J Aust. 2005; 183::520–524.
   [Google Scholar]
8. Mortensen EM, Restrepo M, Anzueto A, et al., Effects of guidelineconcordant antimicrobial therapy on mortality among patients with community-acquired pneumonia. Am J Med. 2004; 117::726–731.
   [Google Scholar]
9. Menendez R, Ferrando D, Valles JM, et al., Influence of deviation from guidelines on the outcome of community-acquired pneumonia. Chest. 2002; 122::612–617.
   [Google Scholar]
10. Foley SC, Kelly EM, O'Neill SJ. Audit of the management of patients admitted with community acquired pneumonia. Ir Med J. 2006; 99::138–140.
    [Google Scholar]
11. Nichol KL, Margolis KL, Wuorenma J, et al., The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med. 1994; 331::778–784.
    [Google Scholar]
12. Fedson DS, Wajda A, Nicol JP, et al., Clinical effectiveness of influenza vaccination in Manitoba. JAMA. 1993; 270::1956–1961.
    [Google Scholar]
13. Foster DA, Talsma A, Furumoto , Dawson A, et al., Influenza vaccine effectiveness in preventing hospitalization for pneumonia in the elderly. Am J Epidemiol. 1992; 136::296–307.
    [Google Scholar]
14. Nichol KL. Complications of influenza and benefits ofvaccination. Vaccine. 1999; 17:Suppl 1:S47–S52.
    [Google Scholar]
15. Fine MJ, Smith MA, Carson CA, et al., Efficacy of pneumococcal vaccination in adults. A meta-analysis of randomized controlled trials. Arch Intern Med. 1994; 154::2666–2767.
    [Google Scholar]
16. Jackson LA, Neuzil KM, Yu O, et al., Effectiveness of pneumococcal polysaccharide vaccine in older adults. N Engl J Med. 2003; 348::1747–1755.
    [Google Scholar]
17. Bero LA, Grilli R, Grimshaw JM, et al., Getting research findings into practice: Closing the gap between research and practice: An overview of systematic reviews of interventions to promote the implementation of research findings. BMJ. 1998; 317::465–468.
    [Google Scholar]
18. Brown EM. Guidelines for antibiotic usage in hospitals. J Antimicrob Chemother. 2002; 49::587–592.
    [Google Scholar]